ATE192436T1 - 3,4-diarryl substituierte pyridine zur behandlung von entzündungen - Google Patents
3,4-diarryl substituierte pyridine zur behandlung von entzündungenInfo
- Publication number
- ATE192436T1 ATE192436T1 AT96903715T AT96903715T ATE192436T1 AT E192436 T1 ATE192436 T1 AT E192436T1 AT 96903715 T AT96903715 T AT 96903715T AT 96903715 T AT96903715 T AT 96903715T AT E192436 T1 ATE192436 T1 AT E192436T1
- Authority
- AT
- Austria
- Prior art keywords
- inflammation
- diarryl
- treatment
- haloalkyl
- halo
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title abstract 3
- 230000004054 inflammatory process Effects 0.000 title abstract 3
- 150000003222 pyridines Chemical class 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000005133 alkynyloxy group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000001769 aryl amino group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyano, carboxyl Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/386,843 US5596008A (en) | 1995-02-10 | 1995-02-10 | 3,4-Diaryl substituted pyridines for the treatment of inflammation |
| PCT/US1996/001110 WO1996024585A1 (en) | 1995-02-10 | 1996-02-08 | 3,4-diaryl substituted pyridines for the treatment of inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE192436T1 true ATE192436T1 (de) | 2000-05-15 |
Family
ID=23527293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96903715T ATE192436T1 (de) | 1995-02-10 | 1996-02-08 | 3,4-diarryl substituierte pyridine zur behandlung von entzündungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5596008A (de) |
| EP (1) | EP0808305B1 (de) |
| AT (1) | ATE192436T1 (de) |
| AU (1) | AU4770796A (de) |
| DE (1) | DE69608096T2 (de) |
| DK (1) | DK0808305T3 (de) |
| ES (1) | ES2145996T3 (de) |
| GR (1) | GR3033428T3 (de) |
| PT (1) | PT808305E (de) |
| WO (1) | WO1996024585A1 (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW527186B (en) * | 1996-03-19 | 2003-04-11 | Janssen Pharmaceutica Nv | Fused imidazole derivatives as multidrug resistance modulators |
| IT1288123B1 (it) * | 1996-09-04 | 1998-09-10 | Nicox Sa | Uso di nitroderivati per l'incontinenza urinaria |
| DE69729946T2 (de) | 1996-10-15 | 2005-01-20 | G.D. Searle Llc | Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia |
| US6525053B1 (en) | 1997-08-22 | 2003-02-25 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| US6307047B1 (en) | 1997-08-22 | 2001-10-23 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
| US7041694B1 (en) | 1997-12-17 | 2006-05-09 | Cornell Research Foundation, Inc. | Cyclooxygenase-2 inhibition |
| US6649645B1 (en) * | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
| US7141673B1 (en) | 1999-01-14 | 2006-11-28 | Lonza Ag | 1-(6-methylpyridine-3-yl)-2-[4-(methylsulphonyl) phenyl] ethanone and method for its preparation |
| IL143981A0 (en) * | 1999-01-14 | 2002-04-21 | Lonza Ag | 1-(6-methylpyridine-3-yl)-2-[4-(methylsulfonyl) phenyl) ethanone and method for its preparation |
| KR100793668B1 (ko) * | 1999-12-08 | 2008-01-10 | 파마시아 코포레이션 | 강화된 생체이용률을 지닌 고체상 형태의 셀레콕시브 |
| GB0003224D0 (en) | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
| PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| JP2004503601A (ja) * | 2000-07-13 | 2004-02-05 | ファルマシア・コーポレーション | 眼のｃｏｘ−２媒介疾患の処置及び予防におけるｃｏｘ−２阻害剤の使用法 |
| GB0021494D0 (en) | 2000-09-01 | 2000-10-18 | Glaxo Group Ltd | Chemical comkpounds |
| US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| PE20021017A1 (es) | 2001-04-03 | 2002-11-24 | Pharmacia Corp | Composicion parenteral reconstituible |
| US6673818B2 (en) | 2001-04-20 | 2004-01-06 | Pharmacia Corporation | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
| GB0112802D0 (en) | 2001-05-25 | 2001-07-18 | Glaxo Group Ltd | Pyrimidine derivatives |
| GB0112810D0 (en) | 2001-05-25 | 2001-07-18 | Glaxo Group Ltd | Pyrimidine derivatives |
| UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
| GB0119477D0 (en) | 2001-08-09 | 2001-10-03 | Glaxo Group Ltd | Pyrimidine derivatives |
| AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
| US7329401B2 (en) | 2002-04-15 | 2008-02-12 | The Regents Of The University Of California | Cyclooxygenase-2 selective agents useful as imaging probes and related methods |
| ATE325115T1 (de) | 2002-08-19 | 2006-06-15 | Glaxo Group Ltd | Pyrimidinderivate als selektive cox-2-inhibitoren |
| GB0221443D0 (en) | 2002-09-16 | 2002-10-23 | Glaxo Group Ltd | Pyridine derivates |
| AU2003303041B2 (en) | 2002-12-13 | 2008-07-24 | Warner-Lambert Company Llc | Alpha-2-delta ligand to treat lower urinary tract symptoms |
| ES2275218T3 (es) | 2003-05-07 | 2007-06-01 | Osteologix A/S | Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos. |
| WO2005044227A1 (en) * | 2003-11-05 | 2005-05-19 | Glenmark Pharmaceuticals Limited | Topical pharmaceutical compositions |
| US20050100594A1 (en) * | 2003-11-12 | 2005-05-12 | Nilendu Sen | Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor |
| BRPI0506994A (pt) | 2004-01-22 | 2007-07-03 | Pfizer | derivados de triazol que inibem a atividade antagonista da vasopressina |
| US7429667B2 (en) * | 2005-01-20 | 2008-09-30 | Ardea Biosciences, Inc. | Phenylamino isothiazole carboxamidines as MEK inhibitors |
| TW200716594A (en) * | 2005-04-18 | 2007-05-01 | Neurogen Corp | Substituted heteroaryl CB1 antagonists |
| EP1767161A1 (de) * | 2005-09-22 | 2007-03-28 | Zimmer Spine, Inc. | Vorrichtung zum Modellieren eines spinalen Fixierungsstabes |
| PL1973884T3 (pl) * | 2006-01-19 | 2017-05-31 | Orchid Pharma Limited | Nowe związki heterocykliczne |
| US7842836B2 (en) | 2006-04-11 | 2010-11-30 | Ardea Biosciences | N-aryl-N'alkyl sulfamides as MEK inhibitors |
| JP5269762B2 (ja) * | 2006-04-18 | 2013-08-21 | アーディア・バイオサイエンシーズ・インコーポレイテッド | Ｍｅｋ阻害剤としてのピリドンスルホンアミドおよびピリドンスルファミド |
| WO2008033466A2 (en) * | 2006-09-14 | 2008-03-20 | Combinatorx (Singapore) Pre. Ltd. | Compositions and methods for treatment of viral diseases |
| CA2673545A1 (en) | 2006-12-22 | 2008-07-03 | Recordati Ireland Limited | Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids |
| EP2114461A2 (de) * | 2007-01-19 | 2009-11-11 | Mallinckrodt Inc. | Diagnostische und therapeutische cyclooxygenase-2-bindende liganden |
| US8509487B2 (en) * | 2007-04-19 | 2013-08-13 | Avago Technologies General Ip (Singapore) Pte. Ltd. | System and method for optically measuring a parameter of an object |
| US8563594B2 (en) | 2007-05-08 | 2013-10-22 | Allergan, Inc. | S1P3 receptor inhibitors for treating pain |
| US11583516B2 (en) | 2016-09-07 | 2023-02-21 | Trustees Of Tufts College | Dash inhibitors, and uses related thereto |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6816241A (de) * | 1967-12-01 | 1969-06-03 | ||
| US3655679A (en) * | 1969-06-25 | 1972-04-11 | Merck & Co Inc | Certain aryl pyridine carboxylic acid derivatives |
| FR2248027B2 (de) * | 1973-10-18 | 1977-09-09 | Serdex | |
| US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
| US5004743A (en) * | 1987-11-25 | 1991-04-02 | Merck Frosst Canada, Inc. | Pyridyl styrene dialkanoic acids as anti-leukotriene agents |
| US5593994A (en) * | 1994-09-29 | 1997-01-14 | The Dupont Merck Pharmaceutical Company | Prostaglandin synthase inhibitors |
-
1995
- 1995-02-10 US US08/386,843 patent/US5596008A/en not_active Expired - Fee Related
-
1996
- 1996-02-08 EP EP96903715A patent/EP0808305B1/de not_active Expired - Lifetime
- 1996-02-08 WO PCT/US1996/001110 patent/WO1996024585A1/en not_active Ceased
- 1996-02-08 AT AT96903715T patent/ATE192436T1/de not_active IP Right Cessation
- 1996-02-08 DE DE69608096T patent/DE69608096T2/de not_active Expired - Fee Related
- 1996-02-08 PT PT96903715T patent/PT808305E/pt unknown
- 1996-02-08 DK DK96903715T patent/DK0808305T3/da active
- 1996-02-08 AU AU47707/96A patent/AU4770796A/en not_active Abandoned
- 1996-02-08 ES ES96903715T patent/ES2145996T3/es not_active Expired - Lifetime
-
2000
- 2000-05-16 GR GR20000401118T patent/GR3033428T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2145996T3 (es) | 2000-07-16 |
| US5596008A (en) | 1997-01-21 |
| EP0808305B1 (de) | 2000-05-03 |
| DE69608096T2 (de) | 2000-11-02 |
| EP0808305A1 (de) | 1997-11-26 |
| DK0808305T3 (da) | 2000-08-28 |
| AU4770796A (en) | 1996-08-27 |
| GR3033428T3 (en) | 2000-09-29 |
| PT808305E (pt) | 2000-10-31 |
| DE69608096D1 (de) | 2000-06-08 |
| WO1996024585A1 (en) | 1996-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE192436T1 (de) | 3,4-diarryl substituierte pyridine zur behandlung von entzündungen | |
| DK0808304T3 (da) | 2,3-substituerede pyridiner til behandling af inflammation | |
| DE69425442D1 (de) | 1,3,5- trisubstituierte pyrazolverbindungen zur behandlung von entzündungen | |
| DK0833839T3 (da) | Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme | |
| DK0772601T3 (da) | 4,5-Substituerede imidazolylforbindelser til behandling af inflammation | |
| NL300128I1 (nl) | Gesubstitueerde isoxyzolen voor de behandeling vanontsteking. | |
| BG101934A (en) | Imidazo(1,2-a)pyridine derivatives | |
| EP1528059A3 (de) | Substituierte Isoxazole zur Behandung von Entzündungen | |
| TR199902060T2 (xx) | Gastrik asit salg�lanmas�n�n inhibisyonu i�in bile�ikler. | |
| NZ332762A (en) | Isobutylgaba and its derivatives for the treatment of pain | |
| ATE210648T1 (de) | 3,4-substituierte pyrazole zur behandlung von entzündungen | |
| JO1613B1 (en) | Derivatives of n - (3-hydroxy-4-piperidnil) dihydrobenzofuran, dihydro-2u-benzopyran or dihydro-benzodoxine) carboxymide | |
| DK0934308T3 (da) | 3-pyridyloxymethylheterocykliske etherforbindelser anvendelige til kontrollering af kemisk synaptisk transmission | |
| ES2193362T3 (es) | Derivados de 2-pirimidinamina y su procedimiento de preparacion de los mismos. | |
| DK0601386T3 (da) | Sulfonamider | |
| AU1729097A (en) | Quinazoline derivatives as vegf inhibitors | |
| RU93035829A (ru) | Производные аминохинолона, замещенные арильной или гетероароматической группой, и анти-вич средства | |
| DK0731795T3 (da) | Substituerede pyrazolylbenzensulfonamider til behandling af inflammation | |
| DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
| FI973440A0 (fi) | Trisubstituoituja fenyylijohdannaisia | |
| NZ333706A (en) | Benzenesulfone derivatives and medicaments | |
| DK142084A (da) | N-phenyl-n'-cycloalkylalkanoyl-piperaziner og fremgangsmaade til fremstilling heraf | |
| DE69623899D1 (de) | Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen | |
| ATE110718T1 (de) | Halogenierte pyrimidin-3-oxid-derivate, deren verwendung für die behandlung und die verhütung von haarausfall und für die wachstumsförderung von haaren. | |
| DK0604183T3 (da) | HIV-protease-inhibitorer anvendelige i behandlingen af AIDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |